Nearly a third of medical device adverse events were not submitted to the FDA within a 30-day regulatory window, with most ...
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...
Lilly has taken a non-exclusive license to deploy Dexcom’s CGM systems – which include app-based remote monitoring and alarm functions – in pen- and pump-based insulin systems that form the ...
Dexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Both groups used a Dexcom G6 Continuous Glucose Monitoring (CGM ... The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ ...
Insulet reported a higher-than-expected profit in the fourth quarter on Thursday, driven by strong demand for its wearable insulin pumps.
"It is a natural evolution of our mission to bring the same AID technology that helped to make Tandem the #1 recommended insulin pump brand by ... Both groups used a Dexcom G6 Continuous Glucose ...